A 12-year retrospective clinical study of patients who received peptide receptor radionuclide therapy for malignant neuroendocrine tumors demonstrates the long-term effectiveness of this treatment, which also allows patients to maintain a high quality of life.
from Top Health News -- ScienceDaily http://bit.ly/2UTsWKl
No comments:
Post a Comment